I am sure the whole House shares my hon. Friend’s concern for his constituent Nicola. Our sympathies are with her and her family and friends. She asked about three things. On the age at which a screening becomes available or is required, that matter has been considered previously and I am sure will be considered again as part of the long-term plan, but I understand that the decision is based on the evidence of the benefits of screenings at certain ages.
My hon. Friend referenced immunotherapy. To date, the National Institute for Health Research has delivered 64 studies of immunotherapy for women with breast cancer, 28 studies are being opened up to recruitment and 14 studies are currently in set-up, but I will ask the Department to respond to him on the specific case of his constituent. On the third point, Nicola is absolutely right. I would urge all women to attend their mammogram appointments—they are vital: they could save your life.